mhurhangee/patent-ind-claim-en huggingface dataset:
Process for the manufacture of the single-layer polymeric battery separator, said method comprising the steps of: providing a plurality of polymeric microfibers having a maximum length of 25 mm and a minimum size of 2 microns; providing a plurality of polymeric nanofibers having a maximum length of 25 mm and a maximum size of 700 nanometers; subjecting said plurality of microfibers and plurality of nanofibers simultaneously to a wetlaid nonwoven fabricating method such that said polymeric microfibers enmesh in a non-uniform pattern with interstices between said microfibers and said polymeric nanofibers become entangled with said microfibers and with said other nanofibers such that said nanofibers are introduced within said interstices between said microfibers as well as on the surface of the substrate formed from said plurality of polymeric microfibers; and subjecting said enmeshed structure to a supercalendering procedure, wherein said procedure entails contact with at least three separate calendering nips, and wherein each calendering nip applies a pressure of at least 87. 56 N/mm (500 lbs/inch) and wherein said. supercalendered enmeshed structure exhibits a maximum thickness of 25 microns and a maximum porosity of 45%. providing a plurality of polymeric microfibers having a maximum length of 25 mm and a minimum size of 2 microns; providing a plurality of polymeric nanofibers having a maximum length of 25 mm and a maximum size of 700 nanometers; subjecting said plurality of microfibers and plurality of nanofibers simultaneously to a wetlaid nonwoven fabricating method such that said polymeric microfibers enmesh in a non-uniform pattern with interstices between said microfibers and said polymeric nanofibers become entangled with said microfibers and with said other nanofibers such that said nanofibers are introduced within said interstices between said microfibers as well as on the surface of the substrate formed from said plurality of polymeric microfibers; and subjecting said enmeshed structure to a supercalendering procedure, wherein said procedure entails contact with at least three separate calendering nips, and wherein each calendering nip applies a pressure of at least 87. 56 N/mm (500 lbs/inch) and wherein said. supercalendered enmeshed structure exhibits a maximum thickness of 25 microns and a maximum porosity of 45%.
A network element comprising a processor configured such that the network element is configured to: configure a user equipment, UE , to transmit a plurality of channel quality indicator, CQI, reports, the plurality of CQI reports comprising at least one of: one CQI report for all static downlink subframes in a radio frame and one CQI report for each flexible downlink subframe in the radio frame, wherein the flexible subframe is configured to dynamically switch between an uplink subframe and a downlink subframe, or one CQI report for all static downlink subframes in a radio frame and one CQI report that includes an average CQI for all flexible downlink subframes in the radio frame; determine flexible subframes and static subframes in a radio frame; send information about the flexible subframes and static subframes to the UE; transmit at least one control signal in at least one flexible subframe at a power that is reduced compared to the power of the same control signal in a static subframe; and signal information relating to the power reduction to the UE . configure a user equipment, UE , to transmit a plurality of channel quality indicator, CQI, reports, the plurality of CQI reports comprising at least one of: one CQI report for all static downlink subframes in a radio frame and one CQI report for each flexible downlink subframe in the radio frame, wherein the flexible subframe is configured to dynamically switch between an uplink subframe and a downlink subframe, or one CQI report for all static downlink subframes in a radio frame and one CQI report that includes an average CQI for all flexible downlink subframes in the radio frame; one CQI report for all static downlink subframes in a radio frame and one CQI report for each flexible downlink subframe in the radio frame, wherein the flexible subframe is configured to dynamically switch between an uplink subframe and a downlink subframe, or one CQI report for all static downlink subframes in a radio frame and one CQI report that includes an average CQI for all flexible downlink subframes in the radio frame; determine flexible subframes and static subframes in a radio frame; send information about the flexible subframes and static subframes to the UE; transmit at least one control signal in at least one flexible subframe at a power that is reduced compared to the power of the same control signal in a static subframe; and signal information relating to the power reduction to the UE .
A combination comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and lamivudine.
A compound of the formula I wherein: A 1 and A 2 are independently CRs or N, provided at least one of A 1 and A 2 is N; R 1 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 cyanoalkyl, aminocarbonylC 1 -C 6 alkyl, hydroxycarbonylC 1 -C 6 alkyl, C 1 -C 6 nitroalkyl, trimethylsilaneC 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl; C 3 -C 4 cycloalkylC 1 -C 2 alkyl- wherein the C 3 -C 4 cycloalkyl is optionally substituted with 1 or 2 halo atoms; oxetan-3-yl-CH 2 -; or benzyl optionally substituted with halo or C 1 -C 6 haloalkyl; R 2 is phenyl, pyridine, pyrimidine, pyrazine or pyridazine, wherein the phenyl, pyridine, pyrimidine, pyrazine or pyridazine is optionally substituted with one to three substituents, provided the substituent(s) are not on either carbon adjacent to the carbon C=O is attached, and each substituent is independently selected from: C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 thiohaloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, NOz, SF 5 , CN, CONH 2 , COOH and C(S)NH 2 ; R 3 is C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 4 is pyridine, pyrimidine, pyrazine or pyridazine, wherein the pyridine, pyrimidine, pyrazine or pyridazine is substituted with one cyano substituent; R 5 is hydrogen, halogen, CN, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 3 -C 4 cycloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkoxycarbonyl, or di(C 1 -C 3 alkoxy)methane; or a stereoisomer, enantiomer, tautomer and N-oxide of the compound of formula I, or agrochemically acceptable salt thereof. A 1 and A 2 are independently CRs or N, provided at least one of A 1 and A 2 is N; R 1 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 cyanoalkyl, aminocarbonylC 1 -C 6 alkyl, hydroxycarbonylC 1 -C 6 alkyl, C 1 -C 6 nitroalkyl, trimethylsilaneC 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl; C 3 -C 4 cycloalkylC 1 -C 2 alkyl- wherein the C 3 -C 4 cycloalkyl is optionally substituted with 1 or 2 halo atoms; oxetan-3-yl-CH 2 -; or benzyl optionally substituted with halo or C 1 -C 6 haloalkyl; R 2 is phenyl, pyridine, pyrimidine, pyrazine or pyridazine, wherein the phenyl, pyridine, pyrimidine, pyrazine or pyridazine is optionally substituted with one to three substituents, provided the substituent(s) are not on either carbon adjacent to the carbon C=O is attached, and each substituent is independently selected from: C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 thiohaloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, halogen, NOz, SF 5 , CN, CONH 2 , COOH and C(S)NH 2 ; R 3 is C 1 -C 3 alkyl or C 1 -C 3 haloalkyl; R 4 is pyridine, pyrimidine, pyrazine or pyridazine, wherein the pyridine, pyrimidine, pyrazine or pyridazine is substituted with one cyano substituent; R 5 is hydrogen, halogen, CN, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 3 -C 4 cycloalkyl, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, C 1 -C 3 alkoxycarbonyl, or di(C 1 -C 3 alkoxy)methane; or a stereoisomer, enantiomer, tautomer and N-oxide of the compound of formula I, or agrochemically acceptable salt thereof.
An analysis apparatus for analyzing a material component in a urine sample, the analysis apparatus comprising: a flow cell including a flow path along which a urine sample containing a material component flows in use; a branch section configured to cause light passing through the flow path to branch off into a plurality of optical paths; a plurality of imaging devices including at least a first imaging device and a second imaging device for capturing respective images of the sample in the flow path by using the light caused to branch off into the plurality of optical paths, each of the plurality of imaging devices being disposed on a respective one of the plurality of optical paths and configured such that the respective focal points of the plurality of imaging devices are located in the flow path along a common optical axis ; a controller configured to cause the plurality of imaging devices to simultaneously capture the respective images and process the captured images; and at least one variable mechanism configured to change the focal point of a respective imaging device on the optical axis ; wherein the controller is operable in a first mode and a second mode that are analysis modes; and wherein the variable mechanism is further configured to change the focal point of the respective imaging device on the optical axis depending on the first mode and the second mode, so that ranges imaged by the plurality of imaging devices in the direction of the optical axis partially overlap with each other in the first mode and do not overlap with each other in the second mode. a flow cell including a flow path along which a urine sample containing a material component flows in use; a branch section configured to cause light passing through the flow path to branch off into a plurality of optical paths; a plurality of imaging devices including at least a first imaging device and a second imaging device for capturing respective images of the sample in the flow path by using the light caused to branch off into the plurality of optical paths, each of the plurality of imaging devices being disposed on a respective one of the plurality of optical paths and configured such that the respective focal points of the plurality of imaging devices are located in the flow path along a common optical axis ; a controller configured to cause the plurality of imaging devices to simultaneously capture the respective images and process the captured images; and at least one variable mechanism configured to change the focal point of a respective imaging device on the optical axis ; wherein the controller is operable in a first mode and a second mode that are analysis modes; and wherein the variable mechanism is further configured to change the focal point of the respective imaging device on the optical axis depending on the first mode and the second mode, so that ranges imaged by the plurality of imaging devices in the direction of the optical axis partially overlap with each other in the first mode and do not overlap with each other in the second mode.
Exchangeable cartridge device for a measuring apparatus assigned, in particular stationarily, to at least one drinking water conduit for a measurement of a drinking water contamination in the drinking water conduit by microorganisms , in particular by legionellae, with at least one cartridge housing which can be coupled with the measuring apparatus and with at least one test unit which is arranged at least partially in the cartridge housing , the test unit comprising at least one consumable material configured for carrying out at least one test for measuring the drinking water contamination, the test unit comprising at least one supply unit to provide markers for a marking of the microorganisms , characterised in that the supply unit comprises at least one microdosing unit . with at least one cartridge housing which can be coupled with the measuring apparatus and with at least one test unit which is arranged at least partially in the cartridge housing , the test unit comprising at least one consumable material configured for carrying out at least one test for measuring the drinking water contamination, the test unit comprising at least one supply unit to provide markers for a marking of the microorganisms , characterised in that the supply unit comprises at least one microdosing unit .
Kit comprising multiple plug-in elements which can be connected in order to form connecting elements, and each plug-in element is of a planar design and has receptacles and connecting means , the receptacles being designed in such a manner that at least one connecting means can be inserted into a receptacle , characterised in that each plug-in element has at least one predetermined breaking point so that each plug-in element can be divided into at least two plug-in elements with receptacles and connecting means .
A method, comprising: broadcasting , by a network node in a wireless network, an initial bandwidth part to a user equipment in system information; wherein the method further comprises: selecting , by the network node, at least one bandwidth part based on incoming data type and/or required quality for a connection to be established; sending , by the network node toward a user equipment, an indication of the at least one selected bandwidth part to be used by the user equipment during a connection establishment procedure to connect the user equipment to the wireless network, wherein the at least one selected bandwidth part is wider than the initial bandwidth part, and wherein the at least one selected bandwidth part is sent via paging or system information after the user equipment transition to idle/inactive state, or in a release message (block 625) prior to the user equipment transition to idle/inactive state, for the wider bandwidth part being in use for an msg3 message of random access procedure, and in response to receiving, by the network node and from the user equipment, the msg3 message for a connection establishment procedure in the selected bandwidth part, performing connection establishment. selecting , by the network node, at least one bandwidth part based on incoming data type and/or required quality for a connection to be established; sending , by the network node toward a user equipment, an indication of the at least one selected bandwidth part to be used by the user equipment during a connection establishment procedure to connect the user equipment to the wireless network, wherein the at least one selected bandwidth part is wider than the initial bandwidth part, and wherein the at least one selected bandwidth part is sent via paging or system information after the user equipment transition to idle/inactive state, or in a release message (block 625) prior to the user equipment transition to idle/inactive state, for the wider bandwidth part being in use for an msg3 message of random access procedure, and in response to receiving, by the network node and from the user equipment, the msg3 message for a connection establishment procedure in the selected bandwidth part, performing connection establishment.
Working spotlight for a vehicle featuring a housing , a light source and a light guide system for guiding working light generated by the light source in a predefined direction out of the housing into a working area, where a means of generating a motif is arranged in and/or on the housing for projecting at least one motif onto a projection surface outside of the housing , characterized in that the means of generating a motif features a switching unit for switching between different motifs that can each be projected onto the projection surface outside of the housing and the light source is designed to illuminate the working area and to generate the at least one motif.
An article for generating aerosol comprising a medium part and a filter part , wherein the filter part includes a cooling filter filled with a particulate coolant and the particulate coolant has an average length in the longitudinal direction of from 1.0 to 6.0 mm, wherein the filter part further comprises a tube filter which is located in front of the cooling filter and has a hollow hole having a size at which the particulate coolant does not pass, and wherein the tube filter has a cross-sectional area ratio of an outside of the tube filter and an inside of the hollow hole of from 1:0.10 to 1:0.24. wherein the filter part includes a cooling filter filled with a particulate coolant and the particulate coolant has an average length in the longitudinal direction of from 1.0 to 6.0 mm, wherein the filter part further comprises a tube filter which is located in front of the cooling filter and has a hollow hole having a size at which the particulate coolant does not pass, and wherein the tube filter has a cross-sectional area ratio of an outside of the tube filter and an inside of the hollow hole of from 1:0.10 to 1:0.24.
An adhesive composition having a sea-island structure and comprising a reaction product of an acid-modified polyolefin (A) and a curing agent (C) in a sea, and a reaction product of a thermoplastic resin (B) and the curing agent (C) in islands, wherein the percentage of islands having a particle size of 0.001 to 5 μm is 80% or more of the total number of islands per unit area of 10 μm × 10 um of the adhesive composition, determined as described in the description.
An orally ingestible delivery system for releasing a therapeutic agent within an intestine of a mammal, comprising: the therapeutic agent and a differentially permeable capsule system containing the therapeutic agent within a therapeutic agent compartment, wherein the differentially permeable capsule system is dimensionally adapted for oral ingestion and for passage into a stomach of the mammal and thence into the intestine; wherein the differentially permeable capsule system comprises an acid-resistant shell and a dispersible acid barrier; wherein the dispersible acid barrier is deployed in a locus selected from the group consisting of an external aspect of the acid-resistant shell, an internal aspect within the acid-resistant shell, and an inferior region below the acid-resistant shell, said dispersible acid barrier inhibiting contact between the acid-resistant shell and the gastric juice in the stomach; wherein the dispersible acid barrier forms while the orally-ingestible delivery system is in the stomach; and wherein the dispersible acid barrier is dispersed in the intestine, thereby permitting enzymes in the intestine to reach the therapeutic agent compartment, thereby releasing the therapeutic agent within the intestine. wherein the differentially permeable capsule system is dimensionally adapted for oral ingestion and for passage into a stomach of the mammal and thence into the intestine; wherein the differentially permeable capsule system comprises an acid-resistant shell and a dispersible acid barrier; wherein the dispersible acid barrier is deployed in a locus selected from the group consisting of an external aspect of the acid-resistant shell, an internal aspect within the acid-resistant shell, and an inferior region below the acid-resistant shell, said dispersible acid barrier inhibiting contact between the acid-resistant shell and the gastric juice in the stomach; wherein the dispersible acid barrier forms while the orally-ingestible delivery system is in the stomach; and wherein the dispersible acid barrier is dispersed in the intestine, thereby permitting enzymes in the intestine to reach the therapeutic agent compartment, thereby releasing the therapeutic agent within the intestine. wherein the dispersible acid barrier is deployed in a locus selected from the group consisting of an external aspect of the acid-resistant shell, an internal aspect within the acid-resistant shell, and an inferior region below the acid-resistant shell, said dispersible acid barrier inhibiting contact between the acid-resistant shell and the gastric juice in the stomach; wherein the dispersible acid barrier forms while the orally-ingestible delivery system is in the stomach; and wherein the dispersible acid barrier is dispersed in the intestine, thereby permitting enzymes in the intestine to reach the therapeutic agent compartment, thereby releasing the therapeutic agent within the intestine.
An electromagnetic detector for detecting one or more properties of a product, for example a rod-shaped article, or a semi-finished product of the tobacco industry, comprising a detecting channel which is open on three sides to allow the product to pass through the electromagnetic detector along a pass-through direction (D), wherein in the detecting channel is located an electromagnetic field oriented in a detecting direction parallel to the pass-through direction (D); wherein the electromagnetic detector comprises an emitting probe for creating the electromagnetic field and a receiving probe to receive an electromagnetic field altered by the presence of the product, the probes (4; 5) being positioned inside the electromagnetic detector , characterized in that the emitting probe and the receiving probe comprise, respectively, a terminal emitting portion and a terminal receiving portion which are parallel to the direction of the detection field, and an initial emitting portion and an initial receiving portion connecting the detector to the outside; and wherein the initial emitting portion forms an angle with the terminal emitting portion , the initial receiving portion forms an angle with the terminal receiving portion , wherein the initial emitting portion and the initial receiving portion are straight, and each extends along a respective single axis of extension.
A pesticidal emulsion comprising: (a) an aqueous continuous phase comprising paraquat at a concentration of from 50 to 360 g/l, and at least one polyvinylalcohol-acetate copolymer; (b) a dispersed oil phase comprising a heavy aromatic hydrocarbon solvent; (c) at least one pesticidal active ingredient selected from butafenacil and S-metalochlor dissolved in the dispersed oil phase; (d) a sorbitan ester surfactant; and (e) a polymeric ethoxylated sorbitan ester surfactant; wherein components (d) and (e) are located at the interface between components (a) and (b). (a) an aqueous continuous phase comprising paraquat at a concentration of from 50 to 360 g/l, and at least one polyvinylalcohol-acetate copolymer; (b) a dispersed oil phase comprising a heavy aromatic hydrocarbon solvent; (c) at least one pesticidal active ingredient selected from butafenacil and S-metalochlor dissolved in the dispersed oil phase; (d) a sorbitan ester surfactant; and (e) a polymeric ethoxylated sorbitan ester surfactant;